Aptose Biosciences

$6.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.85%) As of 11:06 AM EST today

Why Robinhood?

You can buy or sell APTO and other stocks, options, and ETFs commission-free!

About APTO

Aptose Biosciences, Inc. Common Shares, also called Aptose Biosciences, is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada. The listed name for APTO is Aptose Biosciences, Inc. Common Shares.

CEO
William G. Rice
Employees
33
Headquarters
Toronto, Ontario
Founded
1986
Market Cap
623.81M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.13M
High Today
$7.03
Low Today
$6.75
Open Price
$6.92
Volume
252.17K
52 Week High
$9.25
52 Week Low
$2.43

Collections

APTO Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 9, After Hours

You May Also Like